Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1999 1
2000 1
2004 1
2006 1
2009 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Grade 2 Nodular Sclerosis Classic Hodgkin Lymphoma"
Page 1
Brentuximab vedotin in the treatment of paediatric patients with relapsed or refractory Hodgkin's lymphoma: Results of a real-life study.
Massano D, Carraro E, Mussolin L, Buffardi S, Barat V, Zama D, Muggeo P, Vendemini F, Sau A, Moleti ML, Verzegnassi F, D'Amico S, Casini T, Garaventa A, Schiavello E, Cellini M, Vinti L, Farruggia P, Perruccio K, Cesaro S, De Santis R, Marinoni M, D'Alba I, Mura RM, Burnelli R, Mascarin M, Pillon M. Massano D, et al. Pediatr Blood Cancer. 2022 Oct;69(10):e29801. doi: 10.1002/pbc.29801. Epub 2022 Jun 2. Pediatr Blood Cancer. 2022. PMID: 35656841
BACKGROUND: Brentuximab vedotin (BV) is an antibody drug-conjugated anti-CD30 approved for the treatment of adult classical Hodgkin's lymphoma (HL), whereas it is considered as off-label indication in paediatrics. ...No statistically significant differences b …
BACKGROUND: Brentuximab vedotin (BV) is an antibody drug-conjugated anti-CD30 approved for the treatment of adult classical Hodgki …
Lymphocyte depleted Hodgkin lymphoma: an evaluation with immunophenotyping and genetic analysis.
Slack GW, Ferry JA, Hasserjian RP, Sohani AR, Longtine JA, Harris NL, Zukerberg LR. Slack GW, et al. Leuk Lymphoma. 2009 Jun;50(6):937-43. doi: 10.1080/10428190902930488. Leuk Lymphoma. 2009. PMID: 19455461
Lymphocyte depleted classical Hodgkin lymphoma (LDHL) is a vanishing category of classical Hodgkin lymphoma (CHL); many cases previously placed in this category are now recognised as diffuse large B-cell lymphoma (DLBCL), anaplasti …
Lymphocyte depleted classical Hodgkin lymphoma (LDHL) is a vanishing category of classical Hodgkin lym …
Nodular type of lymphocyte predominant Hodgkin's disease. A clinical study of 50 cases.
Pappa VI, Norton AJ, Gupta RK, Wilson AM, Rohatiner AZ, Lister TA. Pappa VI, et al. Ann Oncol. 1995 Jul;6(6):559-65. doi: 10.1093/oxfordjournals.annonc.a059244. Ann Oncol. 1995. PMID: 8573534 Free article.
BACKGROUND: Lymphocyte predominant Hodgkin's disease (LP-HD), particularly that with a nodular pattern has been suggested to constitute a distinct disorder within the spectrum of Hodgkin's disease, this issue being based on clinical, morphologic …
BACKGROUND: Lymphocyte predominant Hodgkin's disease (LP-HD), particularly that with a nodular pattern has been suggest …
Prognostic significance of T-cell or cytotoxic molecules phenotype in classical Hodgkin's lymphoma: a clinicopathologic study.
Asano N, Oshiro A, Matsuo K, Kagami Y, Ishida F, Suzuki R, Kinoshita T, Shimoyama Y, Tamaru J, Yoshino T, Kitamura K, Fukutani H, Morishima Y, Nakamura S. Asano N, et al. J Clin Oncol. 2006 Oct 1;24(28):4626-33. doi: 10.1200/JCO.2006.06.5342. Epub 2006 Sep 5. J Clin Oncol. 2006. PMID: 16954517
PURPOSE: Classical Hodgkin's lymphoma (CHL) is characterized by Hodgkin's and Reed-Sternberg (H-RS) cells, most of which are derived from germinal-center B cells. ...PATIENTS AND METHODS: Participants were 324 consecutive CHL patients, comprising 132 p …
PURPOSE: Classical Hodgkin's lymphoma (CHL) is characterized by Hodgkin's and Reed-Sternberg (H-RS) cells, most …
The pattern of lymphoma in east Malaysian patients as experienced in the University Hospital, Kuala Lumpur.
Chai SP, Peh SC, Kim LH, Lim MY, Gudum HR. Chai SP, et al. Malays J Pathol. 1999 Jun;21(1):45-50. Malays J Pathol. 1999. PMID: 10879278
With the use of a panel of lymphoid antibodies, the disease was sub-classified using the Rye classification for Hodgkin's lymphoma (HL) and the REAL classification for non-Hodgkin's lymphoma (NHL). ...The HL:NHL ratio was 1:9. The most common tu …
With the use of a panel of lymphoid antibodies, the disease was sub-classified using the Rye classification for Hodgkin's l …
Limited field radiotherapy for early stage, infra-diaphragmatic Hodgkin's lymphoma.
Harris MA, Radford JA, Deakin DP, James RD, Swindell R, Cowan RA. Harris MA, et al. Clin Oncol (R Coll Radiol). 2004 Feb;16(1):53-7. doi: 10.1016/j.clon.2003.08.007. Clin Oncol (R Coll Radiol). 2004. PMID: 14768756
Fifteen of the 33 patients were stage IA, 15 were IIA, 1 was IB and 2 were IIB. The median follow-up was 71 months. Histological subtype was lymphocyte predominant (15/33), nodular sclerosis (11/33), mixed cellularity (4/33), lymphocyte-rich classical …
Fifteen of the 33 patients were stage IA, 15 were IIA, 1 was IB and 2 were IIB. The median follow-up was 71 months. Histological subt …
Tissue eosinophilia correlates strongly with poor prognosis in nodular sclerosing Hodgkin's disease, allowing for known prognostic factors.
von Wasielewski R, Seth S, Franklin J, Fischer R, Hübner K, Hansmann ML, Diehl V, Georgii A. von Wasielewski R, et al. Blood. 2000 Feb 15;95(4):1207-13. Blood. 2000. PMID: 10666192 Free article.
Although eosinophilic granulocytes are frequently observed in lymphatic tissue of Hodgkin's patients, no substantial data reveal the prognostic role, if any, of tissue eosinophilia. Thus, eosinophilia was analyzed histologically in 1511 diagnostic biopsy specimens of patie …
Although eosinophilic granulocytes are frequently observed in lymphatic tissue of Hodgkin's patients, no substantial data reveal the …